Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Novel treatment options for iron overloading divulged in recent Xenon patents

Nov. 20, 2008

Nabi reports final results from phase II immunogenicity study of NicVAX

Oct. 31, 2008

Aphios receives phase I SBIR grant from NIDA to develop dronabinol for marijuana addiction

Oct. 29, 2008

PharmAthene initiates phase I trial of nerve agent bioscavenger Protexia

Oct. 29, 2008

Evotec reports results from phase I safety study of EVT-302

Oct. 29, 2008

Anti-flunitrazepam monoclonal antibody prevents sedative and cognitive effects of flunitrazepam

Oct. 23, 2008

Avigen initiates exploratory study of AV-411 in opioid withdrawal

Oct. 16, 2008

Cellerant Therapeutics receives contract for acute radiation syndrome treatment

Sep. 29, 2008

Evotec initiates phase II proof-of-concept EVT-302 trial in smoking cessation

Sep. 16, 2008

Pilot study finds effect of tiagabine in alcoholism

Sep. 2, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...